Sompo Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Sell
4,930
-30
-0.6% -$3.95K 0.1% 112
2026
Q1
$691K Hold
4,960
0.13% 105
2025
Q4
$609K Sell
4,960
-1,590
-24% -$193K 0.1% 117
2025
Q3
$727K Sell
6,550
-270
-4% -$30.7K 0.13% 102
2025
Q2
$756K Buy
6,820
+80
+1% +$8.51K 0.13% 106
2025
Q1
$755K Buy
6,740
+1,080
+19% +$111K 0.14% 102
2024
Q4
$523K Hold
5,660
0.09% 135
2024
Q3
$475K Buy
5,660
+770
+16% +$58.8K 0.07% 147
2024
Q2
$336K Sell
4,890
-220
-4% -$14.7K 0.06% 169
2024
Q1
$374K Sell
5,110
-5,720
-53% -$440K 0.06% 168
2023
Q4
$877K Buy
10,830
+1,860
+21% +$145K 0.16% 96
2023
Q3
$672K Sell
8,970
-490
-5% -$37.7K 0.15% 114
2023
Q2
$729K Sell
9,460
-15,070
-61% -$1.2M 0.14% 103
2023
Q1
$2.04M Sell
24,530
-22,250
-48% -$1.84M 0.43% 59
2022
Q4
$4.02M Sell
46,780
-25,030
-35% -$1.98M 0.92% 32
2022
Q3
$4.43M Buy
71,810
+14,670
+26% +$925K 1.13% 24
2022
Q2
$3.53M Buy
57,140
+43,740
+326% +$2.71M 0.89% 33
2022
Q1
$796K Sell
13,400
-1,620
-11% -$104K 0.17% 106
2021
Q4
$1.09M Buy
15,020
+3,510
+30% +$242K 0.22% 100
2021
Q3
$803K Sell
11,510
-1,920
-14% -$135K 0.18% 112
2021
Q2
$925K Buy
13,430
+1,720
+15% +$115K 0.19% 111
2021
Q1
$757K Sell
11,710
-1,890
-14% -$122K 0.17% 109
2020
Q4
$792K Hold
13,600
0.17% 107
2020
Q3
$859K Sell
13,600
-60
-0.4% -$4.16K 0.21% 100
2020
Q2
$1.05M Sell
13,660
-21,860
-62% -$1.68M 0.27% 90
2020
Q1
$2.65M Sell
35,520
-4,970
-12% -$343K 0.7% 46
2019
Q4
$2.63M Buy
+40,490
New +$2.64M 0.62% 55

Other funds holding GILD

Sompo Asset Management's GILD Position: Q2 2026 in Review

Sompo Asset Management reduced its Gilead Sciences (GILD) stake by 0.6% in Q2 2026, selling an estimated $3.95K and leaving 4,930 shares worth $623K. The position accounts for 0.1% of the portfolio, ranked #112.

Sompo Asset Management first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.43M in Q3 2022. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sompo Asset Management held 4,930 shares of Gilead Sciences worth $623K as of Q2 2026.
  • Sompo Asset Management sold 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
  • Gilead Sciences made up 0.1% of Sompo Asset Management's portfolio in Q2 2026, its #112 holding.
  • Sompo Asset Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Sompo Asset Management's Gilead Sciences position peaked at $4.43M in Q3 2022.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sompo Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.